HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of de novo BSCL2 Ser90Leu mutation in a Korean family with Silver syndrome and distal hereditary motor neuropathy.

Abstract
Mutations in the Berardinelli-Seip congenital lipodystrophy (BSCL2) gene have been identified in families with distal hereditary motor neuropathy (dHMN) and in families with SPG17-linked Silver syndrome. We studied the first Korean families with clinical features resembling classic Silver syndrome and dHMN type V. Direct sequencing analysis of the BSCL2 gene revealed a Ser90Leu mutation in the proband, a younger sister, and one of two sons of the proband. The clinical patterns in this family include presentation with lower-limb and hand-muscle involvement early in the disease course as well as the presence of Babinski signs with nonprogressive mild spastic paraparesis, resembling classic Silver syndrome and dHMN type V. This study reaffirms the clinical phenotype of the disorders associated with a BSCL2 Ser90Leu mutation and describes a genetically proven family with Silver syndrome and dHMN type V in Asia.
AuthorsHyun-Jung Cho, Duk-Hyun Sung, Chang-Seok Ki
JournalMuscle & nerve (Muscle Nerve) Vol. 36 Issue 3 Pg. 384-6 (Sep 2007) ISSN: 0148-639X [Print] United States
PMID17486577 (Publication Type: Journal Article)
Chemical References
  • BSCL2 protein, human
  • GTP-Binding Protein gamma Subunits
  • Serine
  • Leucine
Topics
  • Adolescent
  • Adult
  • Amino Acid Substitution
  • DNA Mutational Analysis
  • Female
  • GTP-Binding Protein gamma Subunits (genetics)
  • Humans
  • Korea
  • Leucine (chemistry, genetics)
  • Male
  • Mutation, Missense
  • Pedigree
  • Reflex, Babinski
  • Serine (chemistry, genetics)
  • Spastic Paraplegia, Hereditary (genetics, physiopathology)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: